Zepbound® contains tirzepatide, which was approved for weight loss in November 2023. It is currently available in auto-injection pens and single use vials. Single use vials are only available from LillyDirect for cash-pay buyers who aren’t using insurance. This injectable medication is renowned for its dual function on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. Tirzepatide mimics the effects of GLP-1, a long-acting version of a natural hormone that helps people feel full when they eat. It helps reduce portion sizes and feelings of hunger between meals.. It also helps control, slows gastric emptying and helps control blood sugars.
Weight loss medications like Zepbound® require purposeful lifestyle changes, including low calorie nutritious meal plans, regular exercise, and muscle building. Using weight management medications without integrating these changes may only provide temporary effects, rather than long-term results.
Benefits of Zepbound® include:
- Revolutionary dual mechanism: Zepbound® combines appetite regulation and metabolic enhancement, setting it apart from traditional weight loss approaches.
- Effective weight loss results: Potential to experience noticeable changes in your weight within weeks, making Zepbound® an effective solution for those seeking quick results.
- Clinically proven: Backed by scientific research, rigorous studies, and clinical trials support tirzepatide's efficacy in weight loss, leading to a weight loss of up to 20.9% total body weight in some individuals, although results may vary.1*
- FDA approved to treat moderate to severe sleep apnea in combination with a comprehensive weight loss program.
Committed to tailored weight management solutions, we recognize Zepbound® as an excellent choice for many. However, we want to suggest alternative options for individuals seeking the most suitable treatment. Depending on availability and insurance coverage, our physicians may recommend or prescribe other GLP-1 options:
- Compounded tirzepatide: Compounded tirzepatide is authorized as an alternative to Zepbound® only while Zepbound® is listed on the FDA drug shortage list. Now that it is no longer in shortage, compounded tirzepatide can no longer be prescribed. However, Zepbound® vials are now available for cash payment at similar prices in four strengths when prescribed through our preferred, licensed pharmacy: 2.5mg, 5mg, 7.5mg, and 10mg.
- Wegovy® (semaglutide): Administered through a convenient weekly injection, Wegovy® stands as a leading weight management medication designed to complement a balanced lifestyle.
Other weight loss medications our doctors may prescribe include:
Availability for compounded tirzepatide is limited to residents in the following states:
Compounded Tirzepatide: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, WA, WV, Washington D.C., WY.
Although compounded tirzepatide is not FDA-approved, our preferred pharmacy provider complies with all federal and state laws and FDA regulations.